Debate continues in the medical literature on the role of the renin angiotensin system (RAS) in Coronavirus disease 2019 (COVID-19) pathophysiology and the implications for the use of cardiovascular drugs acting on the RAS. Could these drugs – which include angiotensin converting enzyme inhibitors (ACEIs) and angiotensin receptors blockers (ARBs) – be harmful or potential key therapeutic agents in COVID-19? And, could potentially helpful measures be available and in plain view on the pharmacy shelf?
All Keywords
【저자키워드】 Vitamin D, Angiotensin receptor blockers, neprilysin, COVID 19, Angiotensin converting enzyme inhibitors, renin angiotensin system,
【저자키워드】 Vitamin D, Angiotensin receptor blockers, neprilysin, COVID 19, Angiotensin converting enzyme inhibitors, renin angiotensin system,